-
admin
Posts
The Nature Trust of BC and GCT Global Container Terminals Lead Successful Boundary Bay Shoreline Clean Up
More than 20 volunteers collected 175 lbs of garbage from the shoreline and surrounding area, helping to preserve the natural beauty and ecological health of...
Platform81 Expands to Wiltshire with New Office in Trowbridge
TROWBRIDGE, United Kingdom, Sept. 23, 2024 (GLOBE NEWSWIRE) — Platform81, a leading web development and digital marketing agency, has announced the opening of its newest...
INTRODUCING IKE’S LOVE: REWARDS WITH RIZZ
San Francisco, CA, Sept. 23, 2024 (GLOBE NEWSWIRE) — Ready to turn up the charm with your favorite sandwich? Ike’s Love & Sandwiches is excited...
Tea Extract Market is expected to generate a revenue of USD 8.23 Billion by 2031, Globally, at 7.67% CAGR: Verified Market Research®
Verified Market Research® is thrilled to announce the release of its comprehensive and authoritative report on the Tea Extract Market – Size and Forecast. With...
Lensmart Updates Flash Sale Campaign: up to 90% off
CHICAGO, Sept. 23, 2024 (GLOBE NEWSWIRE) — It’s now the season of beautiful and colorful leaves around you as autumn is already upon us. As...
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference....
Smart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders’ Equity Following Successful Restructuring Efforts
Company Files Annual 10-K Report with Full Financial Results MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (OTC: SMFL) (“Smart for Life”...
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
Châtillon, France, September 23, 2024 DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and...
BioVie Inc. Announces Proposed Public Offering
CARSON CITY, Nev., Sept. 23, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for...
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
QIAGEN chooses Bode Technology as its exclusive global commercial partner to accelerate use of GEDmatch PRO genealogy database in law enforcement and identification of human...
